Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruption

被引：0
作者：
Steven G. Allen
Chao Zhang
Shawn Malone
Soumyajit Roy
Robert T. Dess
William C. Jackson
Rohit Mehra
Corey Speers
Arul M. Chinnaiyan
Yilun Sun
Daniel E. Spratt
机构：
[1] University of Michigan,Department of Radiation Oncology
[2] Ottawa Hospital Research Institute,Department of Radiation Oncology, The Ottawa Hospital Cancer Center
[3] University of Michigan,Department of Pathology
[4] Case Western Reserve University,Department of Radiation Oncology, UH Seidman Cancer Center
[5] University of Michigan,Rogel Cancer Center and Michigan Center for Translational Pathology
[6] Case Western Reserve University,Department of Population Quantitative Health Sciences
来源：
World Journal of Urology | 2023年 / 41卷
关键词：
Prostate cancer; Androgen receptor; Adjuvant hormone therapy; Radiotherapy; Homologous recombination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3877 / 3887
页数：10
相关论文
共 50 条
[31]   Camptothecin disrupts androgen receptor signaling and suppresses prostate cancer cell growth [J].
Liu, Shicheng ;
Yuan, Yiming ;
Okumura, Yutaka ;
Shinkai, Norihiro ;
Yamauchi, Hitoshi .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 394 (02) :297-302
[32]   Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides [J].
Iris E Eder ;
Zoran Culig ;
Reinhold Ramoner ;
Martin Thurnher ;
Thomas Putz ;
Claudia Nessler-Menardi ;
Martin Tiefenthaler ;
Georg Bartsch ;
Helmut Klocker .
Cancer Gene Therapy, 2000, 7 :997-1007
[33]   Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival [J].
Qing Yang ;
Kar-Ming Fung ;
Wanda V Day ;
Bradley P Kropp ;
Hsueh-Kung Lin .
Cancer Cell International, 5
[34]   Targeting the androgen receptor signaling pathway in advanced prostate cancer [J].
Chung, Clement ;
Abboud, Karen .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (15) :1224-1235
[35]   Interaction of IGF signaling and the androgen receptor in prostate cancer progression [J].
Wu, Jennifer D. ;
Haugk, Kathy ;
Woodke, Libby ;
Nelson, Peter ;
Coleman, Ilsa ;
Plymate, Stephen R. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 99 (02) :392-401
[36]   Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides [J].
Eder, IE ;
Culig, Z ;
Ramoner, R ;
Thurnher, M ;
Putz, T ;
Nessler-Menardi, C ;
Tiefenthaler, M ;
Bartsch, G ;
Klocker, H .
CANCER GENE THERAPY, 2000, 7 (07) :997-1007
[37]   Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival [J].
Yang, Qing ;
Fung, Kar-Ming ;
Day, Wanda V. ;
Kropp, Bradley P. ;
Lin, Hsueh-Kung .
CANCER CELL INTERNATIONAL, 2005, 5 (1)
[38]   RhoGDIα Downregulates Androgen Receptor Signaling in Prostate Cancer Cells [J].
Zhu, Yezi ;
Liu, Chengfei ;
Tummala, Ramakumar ;
Nadiminty, Nagalakshmi ;
Lou, Wei ;
Gao, Allen C. .
PROSTATE, 2013, 73 (15) :1614-1622
[39]   Combining prostate cancer radiotherapy with therapies targeting the androgen receptor axis [J].
Ghashghaei, M. ;
Kucharczyk, M. ;
Elakshar, S. ;
Muanza, T. ;
Niazi, T. .
CURRENT ONCOLOGY, 2019, 26 (05) :E640-E650
[40]   TAS3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer [J].
Yoshida, Shohei ;
Kajiwara, Daisuke ;
Seki, Masanao ;
Tayama, Manabu ;
Tanaka, Yuki ;
Mizutani, Hiroya ;
Fujita, Ryoto ;
Yamamura, Keisuke ;
Okajima, Shigeo ;
Asai, Masanori ;
Minamiguchi, Kazuhisa .
MOLECULAR ONCOLOGY, 2024, 18 (08) :1980-2000
12345